We are live on ! Find out more

141 hedge funds and large institutions have $597M invested in Stride in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 47 increasing their positions, 51 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

10% more capital invested

Capital invested by funds: $546M → $597M (+$51.9M)

4.35% more ownership

Funds ownership: 80.95%85.3% (+4.4%)

1% more funds holding

Funds holding: 140141 (+1)

8% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 51

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
141
Holders Change
+1
Holders Change %
+0.71%
% of All Funds
3.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
47
Reduced
51
Closed
18
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$987K

LRN Hedge Fund Activity: Q3 2018 in Review

141 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Stride (LRN) for Q3 2018, worth a combined $597M — up 9.5% from $546M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new LRN positions and 18 closed out — a net gain of 3 holders — while 47 added to existing stakes and 51 trimmed.

The largest buyer was Assenagon Asset Management, opening a new position worth an estimated $8.88M. The largest seller was Morgan Stanley, cutting an estimated $8.05M.

  • 141 institutional investors held Stride (LRN) as of Q3 2018, up from 140 in Q2 2018.
  • Funds reported $597M of Stride stock for Q3 2018, up 9.5% quarter-over-quarter.
  • 21 funds opened new Stride positions in Q3 2018 and 18 closed out, a net change of +3 holders.
  • The largest Stride buyer in Q3 2018 was Assenagon Asset Management, an estimated $8.88M added.
  • The largest Stride seller in Q3 2018 was Morgan Stanley, an estimated $8.05M sold.

Based on aggregated 13F filings for Q3 2018.